EGFR inhibitors

250 Pill - brown round

Pill with imprint 250 is Brown, Round and has been identified as Gefitinib 250 mg. It is supplied by Teva Pharmaceuticals USA, Inc.

Gefitinib is used in the treatment of Non-Small Cell Lung Cancer and belongs to the drug class EGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Gefitinib 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Gefitinib (Gefitinib [ ge-fi-ti-nib ])-250-250 mg-Brown-Round

Gefitinib
Generic Name: gefitinib [ ge-fi-ti-nib ]
Imprint: 250
Strength: 250 mg
Color: Brown
Size: N/A
Shape: Round
Availability: Prescription only
Drug Class: EGFR inhibitors
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00480-4053
Inactive Ingredients:
Latest News
Related Drugs